On pharmacodynamics, because receptors are the primary molecular targets through which drugs act to produce physiological effects.
These are organized all major receptor classes in the human body by superfamily, with examples, functions, and signaling mechanisms.
OVERVIEW OF RECEPTOR SUPERFAMILIES
Pharmacodynamics divides receptors into four major classes based on signal transduction mechanisms:
| Class |
Location / Speed |
Signal Mechanism |
Examples |
Response Time |
| 1️⃣ Ion channel–linked receptors (ligand-gated ion channels) |
Cell membrane |
Ion flux changes membrane potential or [Ca²⁺], [Na⁺], [Cl⁻], [K⁺] |
Nicotinic ACh, GABA-A, NMDA |
Milliseconds |
| 2️⃣ G protein–coupled receptors (GPCRs) |
Cell membrane |
Activates G proteins → second messengers (cAMP, IP₃, DAG, Ca²⁺) |
Adrenergic, Muscarinic, Dopamine, Serotonin |
Seconds |
| 3️⃣ Enzyme-linked receptors (usually tyrosine kinases) |
Cell membrane |
Ligand binding → dimerization → autophosphorylation → MAPK/PI3K pathways |
Insulin, EGFR, VEGFR |
Minutes to hours |
| 4️⃣ Nuclear receptors (gene transcription regulators) |
Cytoplasm/nucleus |
Ligand binds → transcription modulation |
Steroid hormones, thyroid hormone, vitamin D |
Hours to days |
1. ION CHANNEL–LINKED RECEPTORS (Ligand-Gated Ion Channels)
Mechanism:
Ligand binds → channel opens → ion influx or efflux → depolarization/hyperpolarization → cell response.
| Receptor |
Endogenous Ligand |
Ion Conductance |
Main Function |
Drugs / Modulators |
| Nicotinic acetylcholine receptor (nAChR) |
Acetylcholine |
Na⁺, K⁺ |
Skeletal muscle contraction, autonomic ganglia transmission |
Succinylcholine, Nicotine, Curare |
| GABA-A receptor |
GABA |
Cl⁻ influx |
Inhibitory neurotransmission (hyperpolarization) |
Benzodiazepines, Barbiturates |
| Glycine receptor |
Glycine |
Cl⁻ influx |
Spinal inhibitory neurotransmission |
Strychnine (antagonist) |
| NMDA receptor (Glutamate) |
Glutamate + Glycine |
Ca²⁺, Na⁺ influx |
Memory, learning, excitatory signaling |
Ketamine, PCP |
| AMPA receptor (Glutamate) |
Glutamate |
Na⁺ influx |
Fast excitatory neurotransmission |
|
| 5-HT3 receptor |
Serotonin |
Na⁺, K⁺ |
GI motility, emesis |
Ondansetron (antagonist) |
2. G PROTEIN–COUPLED RECEPTORS (GPCRs)
Mechanism:
Ligand binds → G protein (Gs, Gi, or Gq) activation → second messenger system → effector response.
| G Protein Type |
Second Messenger |
Effect |
| Gs |
↑ cAMP (via adenylate cyclase) |
Activates PKA → ↑ Ca²⁺ influx, ↑ heart rate |
| Gi |
↓ cAMP |
Inhibits PKA → ↓ heart rate, neuronal inhibition |
| Gq |
↑ IP₃/DAG → ↑ intracellular Ca²⁺ |
Smooth muscle contraction, secretion |
Common GPCR Receptors:
| Receptor |
G Protein |
Major Function |
Example Drugs |
| β₁, β₂, β₃ adrenergic |
Gs |
↑ HR, bronchodilation, lipolysis |
Epinephrine, Albuterol |
| α₂ adrenergic |
Gi |
↓ NE release (autoreceptor) |
Clonidine |
| α₁ adrenergic |
Gq |
Vasoconstriction (smooth muscle) |
Phenylephrine |
| Muscarinic M₁, M₃, M₅ |
Gq |
↑ Gland secretion, smooth muscle contraction |
Pilocarpine |
| Muscarinic M₂, M₄ |
Gi |
↓ HR, ↓ contractility |
Atropine (antagonist) |
| D₁, D₅ dopamine |
Gs |
Vasodilation (renal), ↑ cAMP |
Dopamine |
| D₂, D₃, D₄ dopamine |
Gi |
↓ Prolactin release, reward pathway |
Haloperidol |
| H₁ histamine |
Gq |
Allergy, vasodilation, bronchoconstriction |
Diphenhydramine |
| H₂ histamine |
Gs |
↑ Gastric acid secretion |
Ranitidine |
| 5-HT1 |
Gi |
Vasoconstriction |
Triptans |
| 5-HT2 |
Gq |
Platelet aggregation, vasoconstriction |
LSD (agonist), Ketanserin (antagonist) |
| 5-HT4,6,7 |
Gs |
↑ GI motility, CNS effects |
Metoclopramide |
| Opioid receptors (μ, κ, δ) |
Gi |
Analgesia, sedation, euphoria |
Morphine, Fentanyl |
3. ENZYME-LINKED RECEPTORS
Mechanism:
Ligand binds → receptor dimerizes → autophosphorylation → recruits signaling proteins → downstream cascades (MAPK, PI3K-Akt, JAK-STAT).
| Receptor |
Ligand |
Main Function |
Pathway Activated |
| Insulin receptor (RTK) |
Insulin |
Glucose uptake, metabolism |
PI3K-Akt, MAPK |
| EGFR (Epidermal Growth Factor Receptor) |
EGF |
Cell growth, proliferation |
MAPK |
| VEGFR |
VEGF |
Angiogenesis |
PLCγ–PKC |
| PDGFR |
PDGF |
Cell growth |
MAPK |
| Cytokine receptors (non-RTK, use JAK-STAT) |
ILs, Interferons, GH |
Immune modulation, growth |
JAK-STAT |
| Guanylyl cyclase-linked receptors |
ANP, NO (soluble form) |
Vasodilation |
↑ cGMP |
4. NUCLEAR (INTRACELLULAR) RECEPTORS
Mechanism:
Lipophilic ligand enters cell → binds cytosolic or nuclear receptor → receptor-ligand complex binds DNA at hormone response elements → regulates gene transcription.
| Receptor Type |
Ligands |
Location |
Function |
| Steroid hormone receptors |
Cortisol, Aldosterone, Estrogen, Progesterone, Testosterone |
Cytoplasm → Nucleus |
Gene expression for metabolism, reproduction |
| Thyroid hormone receptor (TR) |
T₃, T₄ |
Nucleus |
Basal metabolic rate control |
| Vitamin D receptor |
Calcitriol |
Nucleus |
Calcium/phosphate homeostasis |
| Retinoic acid receptor (RAR) |
Retinoids (Vitamin A derivatives) |
Nucleus |
Cell differentiation |
5. OTHER RECEPTOR TYPES / TARGETS IN PHARMACODYNAMICS
| Target Type |
Examples |
Mechanism |
| Transporters |
SERT, NET, DAT |
Reuptake inhibition (SSRIs, cocaine) |
| Enzymes |
ACE, MAO, COX |
Enzyme inhibition (captopril, NSAIDs) |
| Ion channels (voltage-gated) |
Na⁺, Ca²⁺, K⁺ channels |
Blockade or opening alters excitability (lidocaine, verapamil) |
| Structural proteins |
Tubulin (colchicine, vincristine) |
Inhibit microtubule function |
| DNA / RNA |
Anticancer or antiviral drugs |
Inhibit replication or transcription |
Simplified Mnemonic Summary
| Receptor Type |
Signal Molecule |
Time Course |
Example |
| Ion channel |
Ions (Na⁺, K⁺, Cl⁻, Ca²⁺) |
Milliseconds |
GABA-A |
| GPCR |
G proteins (cAMP, IP₃, DAG) |
Seconds |
β-Adrenergic |
| Enzyme-linked |
Kinase cascades |
Minutes |
Insulin |
| Nuclear |
Gene transcription |
Hours–days |
Cortisol |
No comments:
Post a Comment